Keywords
How to Cite
Abstract
Introduction: Establishing cardiovascular risk (CVR) estimators that allow for equal concordance within the subset of the population is important for establishing therapy that provide advantages for each subpopulation.In this article we focus on buying CVR scale in women with type 2 diabetes mellitus.
Objective: Compare between the Framingham, SCORE / REGICOR and ACC / AHA scales in a court of women with diabetes.
Methods: The data collected were between 2014 and 2016 from the population of the Caribbean Endocrinological Center, Barranquilla, Colombia, considering the sociodemographic, anthropometric, and clinical variables. In this study, it was possible to establish comparisons between the Framingham, SCORE/REGICOR and ACC / AHA scales to identify cardiovascular risk levels in women with T2DM.
Results: 100% of the sample (n = 107) were women with a mean age of 58.5 ± 13,646 years, 78 (72.9%) were classified as low risk, 23 (21.5%) intermediate and 6 ( 5.6%) high with the scale The SCORE / REGICOR scale showed 61 (57.0%) at low risk, 45 (42.1%) moderate and 1 (0.9%) high; while ACC / AHA 38 (35.5%) is classified as low risk and 69 (64.5%) as high.
Conclusions: In the present study, a low concordance was observed when comparing the cardiac risk scales (Framingham, SCORE / REGICOR and ACC / AHA) in Colombian women with type two diabetes and it was also observed that age and total cholesterol were the values that more affected variation between the comparative cardiovascular risk scale.
References
Flor LS, Campos MR. The prevalence of diabetes mellitus and its associated factors in the Brazilian adult population: evidence from a population-based survey. Rev Bras Epidemiol. 2017;20(1):16-29. http://dx.doi.org/10.1590/1980-5497201700010002.
Roglic G. WHO Global report on diabetes: A summary. Int J Non-Commun Dis. 2016;1(1):3-8.
Vargas-Uricoechea H, Casas-Figueroa LÁ. Epidemiología de la diabetes mellitus en Sudamérica: la experiencia de Colombia. Clin Investig Arterioscler. 2016;28(5):245-56. https://doi.org/10.1016/j.arteri.2015.12.002.
Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation. 2014;130(16):1374–82. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.010815.
Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482-9c. http://dx.doi.org/10.1093/eurheartj/ehu403.
Minoo F, Mahdavi-Mazdeh M, Abbasi MR, Sohrabi S. Impact of the severity of obesity on microalbuminuria in obese normotensive nondiabetic individuals. J Ren Inj Prev. 2015;4(2):34-8. http://dx.doi.org/10.12861/jrip.2015.08.
Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185-200. http://dx.doi.org/10.7150/ijms.10001.
D’Agostino RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart. 2013;8(1):11-23. http://dx.doi.org/10.1016/j.gheart.2013.01.001.
Gabriel R, Brotons C, Tormo MJ, Segura A, Rigo F, Elosua R, et al. The ERICE-score: the new native cardiovascular score for the low-risk and aged Mediterranean population of Spain. Rev Esp Cardiol (Engl Ed). 2015;68(3):205-15. http://dx.doi.org/10.1016/j.rec.2014.03.019.
VandenBos GR, Winkler JM. An Analysis of the Status of Journals and Research in Psychology from Latin America. Psicol Reflex E Crítica. 2015;28(Suppl 1):82-93. https://doi.org/10.1590/1678-7153.20152840012.
Camacho PA, Otero J, Pérez M, Arcos E, García H, Narvaez C, et al. The spectrum of the dyslipidemia in Colombia: The PURE study. Int J Cardiol. 2019;284:111-7. https://doi.org/10.1016/j.ijcard.2018.10.090.
López-Jaramillo P, Calderón C, Castillo J, Escobar ID, Melgarejo E, Parra GA. Prediabetes in Colombia: Expert Consensus. Colomb Médica. 2017;48(4):191-203. http://dx.doi.org/10.25100/cm.v43i4.3662.
Navarrete S, Huertas D, Rozo JE, Ospina JE. Prevalencia de factores de riesgo para enfermedad cardiovascular en una muestra de pacientes con hipertensión arterial esencial: estudio descriptivo. Rev Colomb Cardiol. 2009;16(2):64-70.
Machado-Alba JE, Machado-Duque ME. Prevalencia de factores de riesgo cardiovascular en pacientes con dislipidemia afiliados al sistema de salud en Colombia. Rev Peru Med Exp Salud Publica. 2013 [cited abril 11 2020];30(2):205-11. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_abstract&pid=S1726-46342013000200007&lng=es&nrm=iso&tlng=es.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724.https://dx.doi.org/10.1016/S0140-6736(16)31679-8.
Gil-Guillén V, Orozco-Beltrán D, Maiques-Galán A, Aznar-Vicente J, Navarro J, Cea-Calvo L, et al. Concordancia de las escalas REGICOR y SCORE para la identificación del riesgo cardiovascular alto en la población española. Rev Esp Cardiol. 2007;60(10):1042-50. http://dx.doi.org/10.1157/13111236.
Muñoz OM, Ruiz-Morales ÁJ, Mariño-Correa A, Bustos MM. Concordancia entre los modelos de SCORE y Framingham y las ecuaciones AHA/ACC como evaluadores de riesgo cardiovascular. Rev Colomb Cardiol. 2017;24(2):110-6. https://doi.org/10.1016/j.rccar.2016.06.013.
Strom-Williams JL, Lynch CP, Winchester R, Thomas L, Keith B, Egede LE. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes. Diabetes Technol Ther. 2014;16(7):421-7. https://doi.org/10.1089/dia.2013.0329.
Sekerija M, Poljicanin T, Erjavec K, Liberati-Cizmek AM, Prašek M, Metelko Z. Gender differences in the control of cardiovascular risk factors in patients with type 2 diabetes -a cross-sectional study. Intern Med Tokyo Jpn. 2012;51(2):161-6. https://doi.org/10.2169/internalmedicine.51.6094.
Lister-Del Pino P, León-Amenero G, Leiva-Montejo A, Segura ER. Concordancia entre las escalas de riesgo cardiovascular Procam y Framingham en varones que reciben tratamiento antirretroviral en un Hospital Nacional de Lima, Perú 2013. Rev Peru Med Exp Salud Publica. 2015;32(4):731-8.
García-Valenzuela SM. Concordancia en la evaluación del riesgo cardiovascular entre las escalas Score, Framingham y AHA/ACC en pacientes con dislipidemia en un hospital de altura [tesis]. Trujillo: Universidad Privada Antenor Orrego; 2019 [citado noviembre 20 2020]. Disponible en: http://repositorio.upao.edu.pe/handle/upaorep/4533.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2020 Revista Colombiana de Nefrología